Anna E. Gluskin serves as Executive at GENEREX BIOTECHNOLOGY CORP, where they oversee executive responsibilities. Since joining the company, Anna E. Gluskin has executed 5 insider transactions totaling $390.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 16, 2019 involved purchasing 10,000 shares valued at $5.1K.
Anna E. Gluskin currently holds 226,127 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anna E. Gluskin has been a net buyer of GNBT stock. They have purchased $390.9K and sold $0 worth of shares.
Anna E. Gluskin's most recent insider trade was on Nov 16, 2019, when they purchased 10,000 shares at $0.51 per share.
Get notified when new Form 4 filings are submitted
| $0.04 |
| Discretionary |
| Jun 9, 2014 | ESAQ | $120.0K | Purchase | 480,000 | $0.25 | Discretionary |
| Mar 21, 2014 | ESAQ | $216.0K | Purchase | 864,000 | $0.25 | Discretionary |
| Aug 17, 2007 | GNBT | $0 | Award | 200,000 | $N/A | Discretionary |